Articles from BBAA - Home

1. Pioneering Cancer treatment technology backed by London Seed Capital

   BBAA - Home (Oct 27 2007) Funding Explore Article

   Optical imaging company Michelson Diagnostics has secured £600,000 of early stage funding, enabling it to further enhance its pioneering technology and pursue in-vivo trials in a clinical environment. This innovative, next generation, imaging technology addresses the key need for clinicians to see, during an operation and in real time, the location and extent of a tumour, for a range of cancer types. This enables faster, more accurate cancer surgery, with ... (Read Full Article)
   

   Comment on Article Mentions:   Michelson Diagnostics   Jon Holmes   University College Hospital

1-1 of 1